Experimental design constraints on carcinogenic potency estimates
Journal Article
·
· Journal of Toxicology and Environmental Health; (USA)
- Chemical Industry institute of Toxicology, Research Triangle Park, NC (USA)
The multistage model is used by US regulatory agencies to calculate estimates of the carcinogenic potency ({beta}) of chemicals; the data for these estimates are generally obtained from chronic rodent bioassays. Three quantities characterize each group tested in the chronic bioassay: the dose level, the sample size, and the number responding to the dose. The dose levels tested are fixed by conventional protocols; the typical National Toxicology Program (NTP) experimental design calls for use of the maximum tolerated dose (MTD), one-half and one-fourth MTD, plus a control group. Only rarely are doses even one order of magnitude less than the MTD utilized in chronic bioassays. This experimental design constraint on dose selection limits the possible values of {beta} that can arise from multistage model analyses of chronic bioassay data. Sample size is also constrained by the experimental design of the chronic bioassay; the typical sample size in NTP studies is 50 animals. Occasionally, fewer animals are used, but only rarely are more. The net result of these design constraints is that carcinogenic potency estimates derived from multistage-model analyses of chronic bioassay data may vary within only a narrow range surrounding the inverse maximum dose tested. We have illustrated this by calculating the largest possible finite potency estimates that could have arisen from the experimental designs used to test 82 mouse carcinogens in chronic bioassays. On average these maximum potency estimates were within one order of magnitude of the inverse maximum dose tested.
- OSTI ID:
- 5030129
- Journal Information:
- Journal of Toxicology and Environmental Health; (USA), Journal Name: Journal of Toxicology and Environmental Health; (USA) Vol. 27:3; ISSN JTEHD; ISSN 0098-4108
- Country of Publication:
- United States
- Language:
- English
Similar Records
An overview of the report: Correlation between carcinogenic potency and the maximum tolerated dose: Implications for risk assessment
Preliminary estimates of the virtually safe dose for tumors obtained from the maximum tolerated dose
Experimental design of bioassays for screening and low dose extrapolation
Journal Article
·
Sun Aug 01 00:00:00 EDT 1993
· Risk Analysis; (United States)
·
OSTI ID:5594211
Preliminary estimates of the virtually safe dose for tumors obtained from the maximum tolerated dose
Journal Article
·
Fri Mar 31 23:00:00 EST 1989
· Regul. Toxicol. Pharmacol.; (United States)
·
OSTI ID:6066655
Experimental design of bioassays for screening and low dose extrapolation
Journal Article
·
Thu Feb 28 23:00:00 EST 1985
· Risk Anal.; (United States)
·
OSTI ID:6932832